Definitive Healthcare (NASDAQ:DH – Get Free Report) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 0.320-0.340 for the period, compared to the consensus estimate of 0.370. The company issued revenue guidance of $247.0 million-$251.0 million, compared to the consensus revenue estimate of $258.3 million. Definitive Healthcare also updated its FY24 guidance to $0.32-0.34 EPS.
Definitive Healthcare Trading Down 6.3 %
DH stock traded down $0.25 during midday trading on Friday, reaching $3.70. 1,732,976 shares of the company’s stock traded hands, compared to its average volume of 802,780. The company has a market capitalization of $436.34 million, a P/E ratio of -2.26, a PEG ratio of 3.08 and a beta of 1.30. The company has a debt-to-equity ratio of 0.20, a current ratio of 2.30 and a quick ratio of 2.30. Definitive Healthcare has a fifty-two week low of $3.19 and a fifty-two week high of $11.60. The business has a 50-day moving average price of $5.48 and a two-hundred day moving average price of $7.09.
Definitive Healthcare (NASDAQ:DH – Get Free Report) last posted its quarterly earnings data on Tuesday, May 7th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.04). The firm had revenue of $63.48 million for the quarter, compared to analysts’ expectations of $64.00 million. Definitive Healthcare had a negative net margin of 78.16% and a positive return on equity of 0.51%. Equities research analysts forecast that Definitive Healthcare will post 0.09 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Get Our Latest Stock Analysis on Definitive Healthcare
Definitive Healthcare Company Profile
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
Featured Articles
- Five stocks we like better than Definitive Healthcare
- Stock Dividend Cuts Happen Are You Ready?
- Should You Invest in Bitcoin? Pros and Cons
- About the Markup Calculator
- Amazon Stock is Primed to Rebound Strongly After AI Bubble Bursts
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Shell Stock: Oil & Gas Giant Committed to Buybacks and Dividends
Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.